Meta-analysis of mortality factors after COVID-19 infection in pediatric oncology patients [0.03%]
儿童肿瘤患者感染COVID-19后影响死亡率因素的荟萃分析
Qingchen Liu,Xia Wang,Xueqin Zhou
Qingchen Liu
Objective: There are few clinical studies related to COVID-19 in pediatric cancer patients, and systematic reviews or meta-analyses on its mortality risk factors are particularly lacking. Therefore, we conducted this meta...
Analysis of methylation features associated with neoadjuvant efficacy in HER2-positive breast cancer [0.03%]
HER2阳性乳腺癌新辅助治疗疗效相关的甲基化特征分析
Zibai Guo,Jinhong Wei,Anping Gui et al.
Zibai Guo et al.
Background: Response to trastuzumab-based neoadjuvant therapy in human epidermal growth factor receptor type 2 (HER2)-positive breast cancer is affected by multiple features of the tumor. Few studies have investigated epi...
Case Report: A rare case of hepatic undifferentiated pleomorphic sarcoma: diagnostic dilemmas and multidisciplinary management strategies [0.03%]
个例报告：罕见的肝未分化多形性肉瘤病例的诊断难题和多学科管理策略
Yu Yang,Yiwei Hou,Li Yi et al.
Yu Yang et al.
Undifferentiated pleomorphic sarcoma of the liver is an extremely rare mesenchymal malignancy, and there is limited literature on its clinical manifestations, diagnostic challenges, and therapeutic strategies. The case is unique due to its ...
CHML regulates migration and invasion in hepatocellular carcinoma via transcriptional and metabolic reprogramming [0.03%]
CHML通过转录和代谢重编程调节肝癌迁移和侵袭
Huanqian Cao,Siyu Wang,Li Zhang et al.
Huanqian Cao et al.
Background: Hepatocellular carcinoma (HCC), a prevalent malignant neoplasm, presents significant therapeutic challenges. However, the key factors and mechanisms driving HCC metastasis remain incompletely understood. This ...
Comparative efficacy of holmium laser versus plasma techniques in the surgical management of non-muscle invasive bladder cancer: a meta-analysis [0.03%]
holmium激光与等离子技术治疗非肌层浸润性膀胱癌疗效的meta分析
Dong Li,Jia-Neng Xu,Han-Kai Chen et al.
Dong Li et al.
Background: This systematic review and meta-analysis compared the efficacy of Holmium Laser and Plasma Techniques in treating non-muscle invasive bladder cancer (NMIBC), focusing on surgical duration, safety, and tumor re...
Case Report: Reactive T-cell large granular lymphocytes in the bone marrow of a patient with relapsed/refractory multiple myeloma receiving teclistamab [0.03%]
病例报告：接受Teclistamab治疗复发/难治性多发性骨髓瘤患者的骨髓中反应性T细胞大颗粒淋巴细胞增多症
Erin A Dean,Li-Jun Yang,Robert P Seifert et al.
Erin A Dean et al.
T-cell engager therapies for the management of relapsed/refractory (R/R) multiple myeloma (MM) may lead to neutropenia with or without associated infections, which can limit treatment and efficacy. We present a case of a patient with penta-...
Current practices and challenges in the management of cancer-associated thrombosis: a survey of Italian oncologists [0.03%]
意大利肿瘤学家对癌症相关血栓管理的当前实践和挑战的调查研究
Andrea Antonuzzo,Paola Ermacora,Gaetano Lanzetta et al.
Andrea Antonuzzo et al.
Purpose: This study investigates current practices and challenges in managing cancer-associated thrombosis (CAT) among Italian oncologists, with the objective of evaluating adherence to guidelines for primary thromboproph...
A collision tumor composed of colon adenocarcinoma and large cell neuroendocrine carcinoma with gingival metastasis: a case report [0.03%]
结肠腺癌和大细胞神经内分泌癌碰撞瘤伴牙龈转移1例报告
Zhiqiang Zhang,Junfeng Zhang,Peng Chen et al.
Zhiqiang Zhang et al.
Collision tumors represent a relatively uncommon form of tumor manifestation, characterized by the independent coexistence of multiple distinct types of tumors. Large cell neuroendocrine carcinoma of the colorectum is a rare entity, with li...
Combining immune checkpoint inhibitors with thoracic radiotherapy enhances outcomes in advanced non-small-cell lung cancer: a real-world study [0.03%]
免疫检查点抑制剂与胸部放疗联合治疗可改善晚期非小细胞肺癌的疗效：一项真实世界研究
Yao Zou,Yichong Chen,Xiaojuan Zhou et al.
Yao Zou et al.
Background: We aimed to evaluate the efficacy of thoracic radiotherapy (TRT) combined with immune checkpoint inhibitors (ICIs) in patients with advanced non-small-cell lung cancer (NSCLC) in real-world clinical settings a...
PARP inhibitors in melanoma treatment: potential, challenges, and future directions [0.03%]
聚腺苷二磷酸核糖聚合酶抑制剂在黑色素瘤治疗中的应用：潜力、挑战及未来方向
Angela Anaeme,Karen Moussa,Abdallah N Mansour et al.
Angela Anaeme et al.
Genome integrity is a critical driver of cellular stability, and defects in the processes that maintain genome health are potent sources of cancer progression. Homologous recombination deficiency (HRD), which damages cells through absent or...